Astellas Pharma Inc.
Greenhouse gas emissions & sustainability report data
Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-04-01 to 2024-03-31 (Japan); 2023-01-01 to 2023-12-31 (Overseas) | 122.0K tCO2e/year (Scope 1+2) |
| 2022-04-01 to 2023-03-31 (Japan); 2022-01-01 to 2022-12-31 (Overseas) | 563 kilotons (global) tCO2e/year |
| 2021-04-01 to 2022-03-31 (Japan); 2021-01-01 to 2021-12-31 (Overseas) | 319 kilotons (global) in FY2021 |
| 2020-04 to 2021-03 (Japan); 2020-01 to 2020-12 (Overseas) | 317 kilotons (global) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Achieved close to zero Greenhouse Gas emissions at the Kelly Plant, Ireland (world’s first, applied to limited products).
🌱 ESG Focus Areas
SustainabilityPatient AccessEnvironmental Initiatives